TickerFacts.

A business in context

CORT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382475

  2. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382474

  3. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382463

  4. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382457

  5. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382456

  6. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382450

  7. 4 · Ownership change

    Report date 2026-08-26 · 0001193125-26-374607

  8. 4 · Ownership change

    Report date 2026-08-25 · 0001193125-26-371388

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-050613

  10. 8-K · Current report

    Report date 2026-07-29 · 0001628280-26-050607 · Items 2.02,7.01,9.01

  11. 8-K · Current report

    Report date 2026-06-17 · 0001193125-26-274258 · Items 8.01,9.01

  12. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-254622 · Items 8.01

  13. 8-K · Current report

    Report date 2026-05-21 · 0001628280-26-038793 · Items 5.02,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-028902

  15. 8-K · Current report

    Report date 2026-04-30 · 0001628280-26-028892 · Items 2.02,7.01,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-04-17 · 0001628280-26-025735

  17. 8-K · Current report

    Report date 2026-03-25 · 0001193125-26-123543 · Items 8.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-011091

  19. 8-K · Current report

    Report date 2026-02-24 · 0001628280-26-011080 · Items 2.02,7.01,9.01

  20. 8-K · Current report

    Report date 2026-02-19 · 0001193125-26-059551 · Items 8.01,9.01

  21. 8-K · Current report

    Report date 2026-01-22 · 0001193125-26-018704 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2025-12-31 · 0001193125-25-338184 · Items 8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-048841

  24. 8-K · Current report

    Report date 2025-11-04 · 0001628280-25-048814 · Items 2.02,7.01

  25. 8-K · Current report

    Report date 2025-10-10 · 0001193125-25-237834 · Items 1.02,9.01

  26. 8-K · Current report

    Report date 2025-10-06 · 0001193125-25-231963 · Items 5.02,9.01

  27. 8-K · Current report

    Report date 2025-09-10 · 0001193125-25-199706 · Items 8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-037005

  29. 8-K · Current report

    Report date 2025-07-31 · 0001628280-25-036999 · Items 2.02,7.01

  30. 8-K · Current report

    Report date 2025-07-14 · 0001193125-25-158454 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-06-10 · 0001628280-25-031624 · Items 5.07,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-022173

  33. 8-K · Current report

    Report date 2025-05-05 · 0001628280-25-022167 · Items 2.02,7.01,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0001628280-25-019942

  35. 8-K · Current report

    Report date 2025-03-31 · 0001193125-25-067871 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2025-03-03 · 0001193125-25-044123 · Items 8.01,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-008167

  38. 8-K · Current report

    Report date 2025-02-26 · 0001628280-25-008131 · Items 2.02,7.01,9.01

  39. 8-K · Current report

    Report date 2024-12-30 · 0001193125-24-286917 · Items 8.01,9.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-044322

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 18 transaction rows18SGrant / award: 17 transaction rows17AExercise / conversion: 14 transaction rows14MTax / exercise payment: 4 transaction rows4FGift: 11 transaction rows11G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

64 matching transaction rows. Showing 51–64.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-21
2026-05-26
MAHONEY DAVID LA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
12500.00.0
2026-05-21
2026-05-26
Park KimberlyA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
12500.00.0
2026-05-13
2026-05-15
Robb Gary CharlesG · Gift
Acquired
Common Stock1000.00.0
2026-05-13
2026-05-15
Robb Gary CharlesG · Gift
Acquired
Common Stock1000.00.0
2026-05-13
2026-05-15
Robb Gary CharlesG · Gift
Disposed
Common Stock5300.00.0
2026-05-05
2026-05-07
Guyer WilliamS · Sale
Disposed
Common Stock20000.051.83
2026-05-05
2026-05-07
Guyer WilliamM · Exercise / conversion
Acquired
Common Stock20000.021.65
2026-05-05
2026-05-07
Guyer WilliamM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
20000.00.0
2026-05-01
2026-05-05
BELANOFF JOSEPH KS · Sale
Disposed
Common Stock40000.050.1
2026-04-22
2026-04-24
WILSON JAMES NG · Gift
Disposed
Common Stock2000.00.0
2026-04-07
2026-04-08
Guyer WilliamM · Exercise / conversion
Acquired
Common Stock20000.021.65
2026-04-07
2026-04-08
Guyer WilliamS · Sale
Disposed
Common Stock20000.040.97
2026-04-07
2026-04-08
Guyer WilliamM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
20000.00.0
2026-04-06
2026-04-08
WILSON JAMES NG · Gift
Disposed
Common Stock5000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001088856CORCEPT THERAPEUTICS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Corcept Therapeutics · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$675.04M$718.55M
2023-12-31$482.38M$528.59M
2022-12-31$401.86M$458.44M
2021-12-31$365.98M$450.92M
2020-12-31$353.87M$456.56M
2019-12-31$306.49M$400.28M
2018-12-31$251.25M$334.09M
2017-12-31$159.20M$216.87M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗